1. Low levels of ApoA1 improve risk prediction of type 2 diabetes mellitus 
Xing Wu, MD, PhD, Zhexin Yu, MD, MS, Wen Su, MD, PhD, Daniel A. Isquith, BS, Moni B. Neradilek, MS, Ning Lu, MD, Fusheng Gu, MD, Hongwei Li, MD, PhD, Xue-Qiao Zhao, MD 
Journal of Clinical Lipidology 
Volume 11, Issue 2, Pages (March 2017)
DOI: /j.jacl
Copyright © 2017 National Lipid Association Terms and Conditions

2. Figure 1 Study population and selection.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions

3. Figure 2
Apo A1 vs HDL-C by new diabetes status. Pearson correlation = 0.69, P < .001. APO, apolipoprotein; HDL-C, high-density lipoprotein cholesterol.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions

4. Figure 3
ROC curves for multivariate models for new T2DM. Panel A: black line represents the FDRSM model with AUC = 0.87; red line for adding ApoA1 to the model with AUC = 0.89, gold line that is superimposed with the red line for adding HDL-C/ApoA1 ratio to the model with AUC = 0.89. Panel B: The recently published 4-variable Chinese model in blue with AUC = 0.85; AUC improved to 0.89 when adding ApoA1 to the model in green, to 0.87 when adding HDL-C in purple, and to 0.86 when adding HDL-C/ApoA1 ratio in gold. Apo, apolipoprotein; AUC, area under the curve; FDRSM, Framingham Diabetes Risk Scoring Model; HDL-C, high-density lipoprotein-cholesterol; ROC, receiver operating characteristics; T2DM, type 2 diabetes mellitus.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2017 National Lipid Association Terms and Conditions